The co-expression profile of DNAM-1, TIGIT and TACTILE on conventional CD56− T cells from AML patients was significantly different than the profile observed on healthy donors (p = 0.002), (Figure 2b). This evidence concerns the gene CD226 and acute myeloid leukemia.